GE Healthcare Inc. Life Sciences recalls

FDA enforcement reports naming GE Healthcare Inc. Life Sciences as the recalling firm.

Recall reports: 1
Class I (serious): 0
Most recent report: Dec 26, 2018

Severity

Dec 26, 2018Omnipaque (iohexol) Injection, 180mgI/mL, 20 mL Single-Dose Vial, packaged in 10 x 20 m…Drug · GE Healthcare Inc. Life SciencesDefective Container: vial defect was identified that could potentially impact the container closure and result in a lack of sterility assurance and/or the potential for glass particles.Class II